Insulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH):
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
New York
Nova Biomedical Books
c2010
|
| Schriftenreihe: | Metabolic diseases--laboratory and clinical research series
Novinka (Series) |
| Schlagworte: | |
| Beschreibung: | Includes bibliographical references and index |
| Beschreibung: | viii, 54 p. |
| ISBN: | 9781617284809 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV044089076 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 170217s2010 |||| o||u| ||||||eng d | ||
| 020 | |a 9781617284809 |c Online |9 978-1-61728-480-9 | ||
| 035 | |a (ZDB-30-PAD)EBC3020935 | ||
| 035 | |a (ZDB-89-EBL)EBL3020935 | ||
| 035 | |a (OCoLC)711000219 | ||
| 035 | |a (DE-599)BVBBV044089076 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 082 | 0 | |a 616.3/62 |2 22 | |
| 100 | 1 | |a Yoneda, Masato |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Insulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) |c Masato Yoneda ... [et al.] |
| 264 | 1 | |a New York |b Nova Biomedical Books |c c2010 | |
| 300 | |a viii, 54 p. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Metabolic diseases--laboratory and clinical research series | |
| 490 | 0 | |a Novinka (Series) | |
| 500 | |a Includes bibliographical references and index | ||
| 505 | 0 | |a NAFLD and insulin resistance (IR) -- Pathophysiology of NASH : insulin resistance, free fatty acids, and cytokines -- Adiponectin and NASH -- TNF-[alpha] and NAFLD/NASH -- Leptin and NAFLD/NASH -- Peroxisome proliferators-activated receptors (PPARs) and NAFLD/NASH -- Iron overload and NAFLD/NASH -- Mitochondrial abnormalities and NAFLD/NASH -- Genetic influences in NAFLD/NASH -- Therapeutic strategy for NASH patients -- Natural history of NAFLD -- Conclusions | |
| 650 | 4 | |a Fatty liver | |
| 650 | 4 | |a Insulin resistance | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Paperback |z 978-1-61668-927-8 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Paperback |z 1-61668-927-7 |
| 912 | |a ZDB-30-PAD | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029495921 | ||
Datensatz im Suchindex
| _version_ | 1804177140890992640 |
|---|---|
| any_adam_object | |
| author | Yoneda, Masato |
| author_facet | Yoneda, Masato |
| author_role | aut |
| author_sort | Yoneda, Masato |
| author_variant | m y my |
| building | Verbundindex |
| bvnumber | BV044089076 |
| collection | ZDB-30-PAD |
| contents | NAFLD and insulin resistance (IR) -- Pathophysiology of NASH : insulin resistance, free fatty acids, and cytokines -- Adiponectin and NASH -- TNF-[alpha] and NAFLD/NASH -- Leptin and NAFLD/NASH -- Peroxisome proliferators-activated receptors (PPARs) and NAFLD/NASH -- Iron overload and NAFLD/NASH -- Mitochondrial abnormalities and NAFLD/NASH -- Genetic influences in NAFLD/NASH -- Therapeutic strategy for NASH patients -- Natural history of NAFLD -- Conclusions |
| ctrlnum | (ZDB-30-PAD)EBC3020935 (ZDB-89-EBL)EBL3020935 (OCoLC)711000219 (DE-599)BVBBV044089076 |
| dewey-full | 616.3/62 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.3/62 |
| dewey-search | 616.3/62 |
| dewey-sort | 3616.3 262 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01783nmm a2200385zc 4500</leader><controlfield tag="001">BV044089076</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">170217s2010 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781617284809</subfield><subfield code="c">Online</subfield><subfield code="9">978-1-61728-480-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-30-PAD)EBC3020935</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-89-EBL)EBL3020935</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)711000219</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044089076</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.3/62</subfield><subfield code="2">22</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Yoneda, Masato</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Insulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH)</subfield><subfield code="c">Masato Yoneda ... [et al.]</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">Nova Biomedical Books</subfield><subfield code="c">c2010</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">viii, 54 p.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Metabolic diseases--laboratory and clinical research series</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Novinka (Series)</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">NAFLD and insulin resistance (IR) -- Pathophysiology of NASH : insulin resistance, free fatty acids, and cytokines -- Adiponectin and NASH -- TNF-[alpha] and NAFLD/NASH -- Leptin and NAFLD/NASH -- Peroxisome proliferators-activated receptors (PPARs) and NAFLD/NASH -- Iron overload and NAFLD/NASH -- Mitochondrial abnormalities and NAFLD/NASH -- Genetic influences in NAFLD/NASH -- Therapeutic strategy for NASH patients -- Natural history of NAFLD -- Conclusions</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Fatty liver</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Insulin resistance</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Paperback</subfield><subfield code="z">978-1-61668-927-8</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Paperback</subfield><subfield code="z">1-61668-927-7</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-30-PAD</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029495921</subfield></datafield></record></collection> |
| id | DE-604.BV044089076 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:43:21Z |
| institution | BVB |
| isbn | 9781617284809 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029495921 |
| oclc_num | 711000219 |
| open_access_boolean | |
| physical | viii, 54 p. |
| psigel | ZDB-30-PAD |
| publishDate | 2010 |
| publishDateSearch | 2010 |
| publishDateSort | 2010 |
| publisher | Nova Biomedical Books |
| record_format | marc |
| series2 | Metabolic diseases--laboratory and clinical research series Novinka (Series) |
| spelling | Yoneda, Masato Verfasser aut Insulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) Masato Yoneda ... [et al.] New York Nova Biomedical Books c2010 viii, 54 p. txt rdacontent c rdamedia cr rdacarrier Metabolic diseases--laboratory and clinical research series Novinka (Series) Includes bibliographical references and index NAFLD and insulin resistance (IR) -- Pathophysiology of NASH : insulin resistance, free fatty acids, and cytokines -- Adiponectin and NASH -- TNF-[alpha] and NAFLD/NASH -- Leptin and NAFLD/NASH -- Peroxisome proliferators-activated receptors (PPARs) and NAFLD/NASH -- Iron overload and NAFLD/NASH -- Mitochondrial abnormalities and NAFLD/NASH -- Genetic influences in NAFLD/NASH -- Therapeutic strategy for NASH patients -- Natural history of NAFLD -- Conclusions Fatty liver Insulin resistance Erscheint auch als Druck-Ausgabe, Paperback 978-1-61668-927-8 Erscheint auch als Druck-Ausgabe, Paperback 1-61668-927-7 |
| spellingShingle | Yoneda, Masato Insulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) NAFLD and insulin resistance (IR) -- Pathophysiology of NASH : insulin resistance, free fatty acids, and cytokines -- Adiponectin and NASH -- TNF-[alpha] and NAFLD/NASH -- Leptin and NAFLD/NASH -- Peroxisome proliferators-activated receptors (PPARs) and NAFLD/NASH -- Iron overload and NAFLD/NASH -- Mitochondrial abnormalities and NAFLD/NASH -- Genetic influences in NAFLD/NASH -- Therapeutic strategy for NASH patients -- Natural history of NAFLD -- Conclusions Fatty liver Insulin resistance |
| title | Insulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) |
| title_auth | Insulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) |
| title_exact_search | Insulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) |
| title_full | Insulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) Masato Yoneda ... [et al.] |
| title_fullStr | Insulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) Masato Yoneda ... [et al.] |
| title_full_unstemmed | Insulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) Masato Yoneda ... [et al.] |
| title_short | Insulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) |
| title_sort | insulin resistance and nonalcoholic fatty liver disease nafld nonalcoholic steatohepatitis nash |
| topic | Fatty liver Insulin resistance |
| topic_facet | Fatty liver Insulin resistance |
| work_keys_str_mv | AT yonedamasato insulinresistanceandnonalcoholicfattyliverdiseasenafldnonalcoholicsteatohepatitisnash |